Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Leo Tsang"'
Autor:
Chien-Chang Liao, Meng-Hsiang Chen, Chun-Yen Yu, Leung-Chit Leo Tsang, Chao-Long Chen, Hsien-Wen Hsu, Wei-Xiong Lim, Yi-Hsuan Chuang, Po-Hsun Huang, Yu-Fan Cheng, Hsin-You Ou
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 498 (2022)
Background: Since the advent of a new generation of inflow-sensitive inversion recovery (IFIR) technology, three-dimensional non-contrast-enhanced magnetic resonance angiography is being used to obtain hepatic vessel images without applying gadoliniu
Externí odkaz:
https://doaj.org/article/00af84fc44a548b3a230d4d7c0b6e3da
Autor:
Shilin Zhao, Kris Lok, Zhen Sin, Ye Peng, Heidi Fan, Nitya Nagesh, Martha Choi, Jojo Kwok, Edmond Choi, Xi Zhang, Hogan Wai, Leo Tsang, Samuel Cheng, Matthew Wong, Jie Zhu, Chris Mok, Siew Ng, Francis Chan, Malik Peiris, Leo Poon, Hein Tun
Newborns can acquire immunological protection to SARS-CoV-2 through vaccine-conferred antibodies in human breast milk. However, there are some concerns around lactating mothers with regards to potential short- and long-term adverse events and vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ad4e3c0f134a474a041a4fe96ad5f93
https://doi.org/10.21203/rs.3.rs-2786723/v1
https://doi.org/10.21203/rs.3.rs-2786723/v1
Autor:
Yueh-Sheng Chen, Wei-Xiong Lim, An-Ni Lin, Chao-Long Chen, Leung-Chit Leo Tsang, Chun-Yen Yu, Hsien-Wen Hsu, Yi-Hsuan Chuang, Yu-Fan Cheng, Hsin-You Ou
Publikováno v:
Transplantation Proceedings. 54:386-390
Gadolinium-ethoxybenzyl-diethylene triamine pentaacetic acid (Gd-EOB-DTPA) is a newer magnetic resonance contrast that has the combined effect of conventional and liver-specific contrast. The use of Gd-EOB-DTPA may aid in management of patients with
Autor:
Daniel Leung, Xiaofeng Mu, Jaime Rosa Duque, Samuel Cheng MS, Manni Wang, Wenyue Zhang, Yanmei Zhang, Issan Tam YS, Toby Lee SS, Jennifer Lam HY, Sau Man Chan, Cheuk Hei Cheang, Yuet Chung, Howard Wong HW, Amos Lee MT, Wing Yan Li, Sara Chaothai, Leo Tsang CH, Gilbert T Chua, Kai-Ning Cheong, Elaine Au, Janette Kwok SY, Koon Wing Chan, Patrick Chong, Pamela Lee, Marco HK Ho, Tsz Leung Lee, Tu WW, Malik Peiris, YL Lau
Background Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in adult and pediatric patients with inborn errors of immunity (IEIs) remain unknown. Intradermal vaccination may improve immunogenicity in immunocompromised patients. Our stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d05695ea9550ab3e427aa49a1a7ae2f
https://doi.org/10.22541/au.165629347.75546543/v1
https://doi.org/10.22541/au.165629347.75546543/v1
Autor:
Chien-Chang Liao, Yu-Fan Cheng, Chun-Yen Yu, Leung-Chit Leo Tsang, Chao-Long Chen, Hsien-Wen Hsu, Wan-Ching Chang, Wei-Xiong Lim, Yi-Hsuan Chuang, Po-Hsun Huang, Hsin-You Ou
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3789
Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is a histopathological marker and risk factor for HCC recurrence. We integrated diffusion-weighted imaging (DWI) and magnetic resonance (MR) image findings of tumors into a scoring system
Immunogenicity and reactogenicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescents
Autor:
Yu-Lung Lau, Jaime Rosa Duque, Xiwei Wang, Daniel Leung, Samuel Cheng, Carolyn Cohen, Xiaofeng Mu, Asmaa Hachim, Yanmei Zhang, Sau-Man Chan, Sara Chaothai, Kelvin Kwan, Karl Chan, John Li, Leo Luk, Leo Tsang, Wilfred Wong, Cheuk-Hei Cheang, Timothy Hung, Jennifer Lam, Gilbert Chua, Winnie Tso, Patrick Ip, Niloufar Kavian, Wing Leung, Sophie Valkenburg, Malik Peiris, WENWEI TU, Masashi Mori
For SARS-CoV-2 vaccines, efficacy data for BNT162b2 but not CoronaVac are available in adolescents. Phase II/III studies focused on neutralizing antibody responses in adolescents, neglecting binding antibody and cellular responses that are also impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b8b7e45f1117e2776a5c2a21cbec4f3
https://doi.org/10.21203/rs.3.rs-1327020/v1
https://doi.org/10.21203/rs.3.rs-1327020/v1
Autor:
Malik Peiris, Samuel Cheng, Karl Chan, Leo Luk, John Li, Leo Tsang, Leo Poon, Chris Ka Pun Mok, Susanna SS Ng, Fanny Ko, Chunke Chen, Karen Yiu, Ken Chan, David Hui, Bosco Lam
SARS-CoV-2 Omicron subvariant BA.2 is increasing in some areas of the world and it is important to assess how well current vaccines may protect against this infection. BioNTech Pfizer (BNT162b2) and CoronaVac are widely used COVID-19 vaccines globall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::699de97879284e700e9fb39c9f15ccae
https://doi.org/10.21203/rs.3.rs-1331606/v1
https://doi.org/10.21203/rs.3.rs-1331606/v1
Autor:
Malik Peiris, Samuel Cheng, Chris Ka Pun Mok, Yonna Leung, Susanna Ng, Karl Chan, Fanny Ko, Karen Yiu, Bosco Lam, Eric Lau, Ken Chan, Leo Luk, John Li, Leo Tsang, Leo Poon, Chunke Chen, David Hui
Publikováno v:
Research Square
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Omicron, a novel SARS-CoV-2 variant has emerged and is rapidly becoming the dominant SARS-CoV-2 virus circulating globally. It is important to define reductions in virus neutralizing activity in serum of convalescent or vaccinated individuals to unde